Search

Your search keyword '"Hogan, William J."' showing total 858 results

Search Constraints

Start Over You searched for: Author "Hogan, William J." Remove constraint Author: "Hogan, William J." Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
858 results on '"Hogan, William J."'

Search Results

1. Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience

6. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

7. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

9. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

11. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

12. A Day 14 Endpoint for Acute GVHD Clinical Trials

13. Long-term outcomes of allogeneic stem cell transplant in multiple myeloma

14. Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events

15. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

16. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

18. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

19. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

20. Effective treatment of low-risk acute GVHD with itacitinib monotherapy

24. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

25. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

28. Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation

29. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

30. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

31. Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

32. Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.

34. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases

36. Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

39. Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths

40. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

43. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

50. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

Catalog

Books, media, physical & digital resources